An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy

Jacek P. Szaflik,Tomasz Wysocki,Michal Kowalski,Ireneusz Majsterek,Anna I. Borucka,Janusz Blasiak,Jerzy Szaflik

DOI: https://doi.org/10.1007/s00417-007-0674-6

2007-09-12

Abstract:BackgroundDiabetic retinopathy is a highly prevalent cause of visual loss in Western countries. Vascular endothelial growth factor (VEGF) is a potent angiogenic factor implicated in the development of the proliferative stage of this disease. Reports have suggested that polymorphisms at positions-460 and -634 of the 5′ untranslated region of the VEGF gene increase its basal promoter activity.MethodsTo investigate whether polymorphisms are associated with diabetic retinopathy, 215 patients with type 2 diabetes mellitus (T2DM) were enrolled. Among them, 82 subjects had proliferative diabetic retinopathy (PDR), 72 had non-proliferative diabetic retinopathy (NPDR), and 61 individuals without retinopathy served as controls. Two polymorphisms of the VEGF gene, a G→C transversion at-634 (the G/C polymorphism) and a C→T transition at-460 (the C/T polymorphism), were investigated by restriction fragment length polymorphism PCR and allele-specific PCR respectively.ResultsWe did not find any association between the C/T polymorphism and diabetic retinopathy. However, the G/C polymorphism genotype distribution and the frequency of the C allele were significantly higher in the NPDR group than in control patients (OR = 1.69, 95% CI = 1.03–2.79). Analysis of the distribution of combined genotypes of the VEGF gene revealed the prevalence of the C/C-C/C genotype in NPDR patients (OR = 8.26, 95% CI = 1.79–37.99) and C/G-CC in PDR patients (OR = 3.36, 95% CI = 1.39–8.12).ConclusionsOccurrence of the -634C allele appears to be associated with increased VEGF gene promoter activity, and the G/C polymorphism might serve as a predictive factor for the development of diabetic retinopathy.